How obesity management has shifted toward long-term health outcomes instead of merely achieving short-term weight loss...

GLP-1 agonists can help patients with obesity achieve significant weight loss and associated health benefits We...

There are approximately 270,000 people living with type 2 diabetes in Ireland today. In 2023, a...

Treatment considerations in different types of diabetes Diabetes is a metabolic disease characterised by elevated blood...

Attendees at the Joint Irish-UK Endocrine Meeting 2024 received a tour de force presentation on the...

A practical and clinically-grounded overview of the UK ADOPT (AI-enabled Detection of OsteoPorosis for Treatment) study...

The use of continuous glucose monitoring (CGM) by individuals with type 1 diabetes (T1D) has “revolutionised...

The Hadden Lecture was among the highlights of the Joint Irish-UK Endocrine Meeting. President of the...

The inaugural Joint Irish-UK Endocrine Meeting 2024 took place at the International Convention Centre in Belfast...

In this issue, national and international conference coverage, the top 10 unanswered questions in adults...

Joint Irish-UK Endocrine Meeting, Waterfront Centre, 14-15 October 2024

The HSE has launched an updated clinical guideline for type 1 diabetes and an updated model...